Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Non-Current Debt (2023 - 2025)

Perspective Therapeutics (CATX) has disclosed Non-Current Debt for 3 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Non-Current Debt fell 3.45% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, down 3.45% year-over-year, with the annual reading at $1.6 million for FY2025, 3.45% down from the prior year.
  • Non-Current Debt hit $1.6 million in Q4 2025 for Perspective Therapeutics, down from $1.6 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $1.7 million in Q1 2023 to a low of $1.6 million in Q4 2025.
  • Historically, Non-Current Debt has averaged $1.6 million across 3 years, with a median of $1.6 million in 2024.
  • Biggest five-year swings in Non-Current Debt: dropped 2.92% in 2024 and later dropped 3.45% in 2025.
  • Year by year, Non-Current Debt stood at $1.7 million in 2023, then decreased by 3.04% to $1.6 million in 2024, then dropped by 3.45% to $1.6 million in 2025.
  • Business Quant data shows Non-Current Debt for CATX at $1.6 million in Q4 2025, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.